DE69232007D1 - Abgabesystem für eine wirksubstanz mit verzögerter freisetzung - Google Patents

Abgabesystem für eine wirksubstanz mit verzögerter freisetzung

Info

Publication number
DE69232007D1
DE69232007D1 DE69232007T DE69232007T DE69232007D1 DE 69232007 D1 DE69232007 D1 DE 69232007D1 DE 69232007 T DE69232007 T DE 69232007T DE 69232007 T DE69232007 T DE 69232007T DE 69232007 D1 DE69232007 D1 DE 69232007D1
Authority
DE
Germany
Prior art keywords
delivery system
active substance
delayed release
delayed
release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69232007T
Other languages
English (en)
Other versions
DE69232007T2 (de
Inventor
Bruce Mazer
Alan Meyer
Shie-Ming Hwang
Leonard Candler
R Drayer
Andre Daab-Krzykowski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of DE69232007D1 publication Critical patent/DE69232007D1/de
Application granted granted Critical
Publication of DE69232007T2 publication Critical patent/DE69232007T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5052Proteins, e.g. albumin
DE69232007T 1991-12-31 1992-12-21 Abgabesystem für eine wirksubstanz mit verzögerter freisetzung Expired - Fee Related DE69232007T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/816,412 US5160742A (en) 1991-12-31 1991-12-31 System for delivering an active substance for sustained release
PCT/US1992/011160 WO1993012772A1 (en) 1991-12-31 1992-12-21 System for delivering an active substance for sustained release

Publications (2)

Publication Number Publication Date
DE69232007D1 true DE69232007D1 (de) 2001-09-20
DE69232007T2 DE69232007T2 (de) 2002-04-18

Family

ID=25220519

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69232007T Expired - Fee Related DE69232007T2 (de) 1991-12-31 1992-12-21 Abgabesystem für eine wirksubstanz mit verzögerter freisetzung

Country Status (7)

Country Link
US (1) US5160742A (de)
EP (1) EP0619733B1 (de)
AU (1) AU3418993A (de)
CA (1) CA2122592C (de)
DE (1) DE69232007T2 (de)
MX (1) MX9207263A (de)
WO (1) WO1993012772A1 (de)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5580578A (en) * 1992-01-27 1996-12-03 Euro-Celtique, S.A. Controlled release formulations coated with aqueous dispersions of acrylic polymers
US5968551A (en) * 1991-12-24 1999-10-19 Purdue Pharma L.P. Orally administrable opioid formulations having extended duration of effect
US5472712A (en) * 1991-12-24 1995-12-05 Euroceltique, S.A. Controlled-release formulations coated with aqueous dispersions of ethylcellulose
US5681585A (en) * 1991-12-24 1997-10-28 Euro-Celtique, S.A. Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
US7070806B2 (en) * 1992-01-27 2006-07-04 Purdue Pharma Lp Controlled release formulations coated with aqueous dispersions of acrylic polymers
ES2095001T5 (es) * 1992-12-22 2001-03-16 Univ Cincinnati Una composicion terapeutica administrable oralmente y su metodo de obtencion.
US5645880A (en) * 1993-07-08 1997-07-08 Mcardle; Blaise Protein-polysaccharide complex composition and method of use
FR2710649A1 (fr) * 1993-09-30 1995-04-07 Germinal Sarl Film polymérique à base de prolamines, son procédé de préparation et ses applications .
US5817338A (en) * 1994-07-08 1998-10-06 Astra Aktiebolag Multiple unit tableted dosage form of omeprazole
US5728403A (en) * 1994-10-05 1998-03-17 The Board Of Regents Of The University Of Nebraska Coating technology for taste masking orally administered bitter drugs
US5871751A (en) * 1994-10-12 1999-02-16 The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Renibacterium salmoninarum vaccine and method for its preparation
US5531681A (en) * 1995-01-13 1996-07-02 Abbott Laboratories Apparatus for altering composition of nutritional product during enteral tube feeding
US6277092B1 (en) 1995-01-13 2001-08-21 Abbott Laboratories Apparatus for altering composition of nutritional product during enteral tube feeding
US5531734A (en) * 1995-01-13 1996-07-02 Abbott Laboratories Method of altering composition of nutritional product during enteral tube feeding
SE9500422D0 (sv) * 1995-02-06 1995-02-06 Astra Ab New oral pharmaceutical dosage forms
US5631245A (en) * 1995-06-06 1997-05-20 Biodynamics Pharmaceuticals, Inc. Method for medicating the inflammatory controlling system and adverse inflammatory reactions and for making compounds for treating the pathology of adverse inflammatory reactions
SE9600070D0 (sv) 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
SE512835C2 (sv) * 1996-01-08 2000-05-22 Astrazeneca Ab Doseringsform innehållande en mångfald enheter alla inneslutande syralabil H+K+ATPas-hämmare
SE9600071D0 (sv) 1996-01-08 1996-01-08 Astra Ab New oral formulation of two active ingredients I
SE9600072D0 (sv) * 1996-01-08 1996-01-08 Astra Ab New oral formulation of two active ingredients II
FR2752732B1 (fr) * 1996-08-28 1998-11-20 Pf Medicament Forme galenique a liberation prolongee de milnacipran
WO1999001111A1 (en) 1997-07-02 1999-01-14 Euro-Celtique, S.A. Stabilized sustained release tramadol formulations
WO1999017738A1 (en) 1997-10-03 1999-04-15 Lavipharm Laboratories, Inc. A prolamine-plant polar lipid composition, its method of preparation and applications thereof
WO1999018965A1 (en) * 1997-10-10 1999-04-22 Yamanouchi Europe B.V. Oral compositions containing a cephalosporin antibiotic
US6080132A (en) * 1998-02-27 2000-06-27 Abbott Laboratories Apparatus for altering characteristics of a fluid
US6309373B1 (en) 1998-08-12 2001-10-30 Abbott Laboratories Apparatus for altering the characteristics of a fluid
US6251432B1 (en) 1999-07-01 2001-06-26 Abbott Laboratories Sustained release dosage form unit having latex coating and method of making the same
US6395198B1 (en) 1999-10-01 2002-05-28 Mcardle Biaise Anti-caking and anti-dusting composition and corresponding methods
US20020106408A1 (en) * 2000-12-01 2002-08-08 Johnatan Bacon Prolamin-based sustained-release compositions and delayed-onset compositions
WO2004082679A1 (ja) * 2003-03-17 2004-09-30 Takeda Pharmaceutical Company Limited 放出制御組成物
KR20120080241A (ko) 2003-06-20 2012-07-16 뉴트리니아 리미티드 생활성 화합물의 보호 방법 및 생활성 성분을 포함하는 조성물
US20050147663A1 (en) * 2003-07-17 2005-07-07 Mohan Mailatur S. Method of treatment for improved bioavailability
US20050042277A1 (en) * 2003-07-17 2005-02-24 Irukulla Srinivas Pharmaceutical compositions having a swellable coating
JP2007507491A (ja) * 2003-09-29 2007-03-29 シージェー コーポレーション 徐放性製剤
US20050095300A1 (en) * 2003-10-30 2005-05-05 Wynn David W. Controlled release analgesic suspensions
US20050226929A1 (en) * 2004-04-12 2005-10-13 Jianbo Xie Controlled release opioid analgesic formulation
DE102004026706A1 (de) * 2004-05-28 2005-12-15 Merck Patent Gmbh Orale Darreichungsform enthaltend probiotische Bakterien
FR2872044B1 (fr) * 2004-06-28 2007-06-29 Flamel Technologies Sa Formulation pharmaceutique a base d'antibiotique sous forme microcapsulaire
WO2006052503A2 (en) * 2004-11-04 2006-05-18 Merck & Co Inc Process for granulating particles
US7303766B2 (en) * 2005-02-03 2007-12-04 J.M. Huber Corporation Coated/treated metal silicate absorbent particles
AU2006287399A1 (en) * 2005-09-09 2007-03-15 Kellogg Company Omega-3 fatty acids encapsulated in zein coatings and food products incorporating the same
CA2924200C (en) * 2005-10-12 2017-09-05 Proventiv Therapeutics, Llc Methods and articles for treating 25-hydroxyvitamin d insufficiency and deficiency
CA2882048C (en) 2006-02-03 2020-03-24 Proventiv Therapeutics, Llc Treating vitamin d insufficiency and deficiency with 25-hydroxyvitamin d2 and 25-hydroxyvitamin d3
ES2497494T3 (es) 2006-06-21 2014-09-23 Opko Renal, Llc Método de tratamiento y prevención del hiperparatiroidismo secundario
US8765178B2 (en) 2006-07-19 2014-07-01 Watson Laboratories, Inc. Controlled release formulations and associated methods
WO2008134518A2 (en) * 2007-04-25 2008-11-06 Cytochroma Inc. Methods and compounds for vitamin d therapy
WO2008134523A1 (en) 2007-04-25 2008-11-06 Proventiv Therapeutics, Llc Method of safely and effectively treating and preventing secondary hyperparathyroidism in chronic kidney disease
WO2009047644A2 (en) * 2007-04-25 2009-04-16 Cytochroma Inc. Method of treating vitamin d insufficiency and deficiency
KR20190028822A (ko) 2007-04-25 2019-03-19 사이토크로마 인코포레이티드 비타민 d 화합물과 밀랍성 담체를 포함하는 경구 조절성 방출 조성물
WO2009041945A1 (en) * 2007-09-28 2009-04-02 Capricorn Pharma Inc. Coated compositions and methods for preparing same
TWI391150B (zh) * 2008-01-22 2013-04-01 Taiwan Biotech Co Ltd 腸溶性長效塗覆芯與藥物劑型及其製造方法
US8962239B2 (en) 2008-04-02 2015-02-24 Opko Renal, Llc Methods useful for vitamin D deficiency and related disorders
US9504274B2 (en) * 2009-01-27 2016-11-29 Frito-Lay North America, Inc. Methods of flavor encapsulation and matrix-assisted concentration of aqueous foods and products produced therefrom
US20100310726A1 (en) 2009-06-05 2010-12-09 Kraft Foods Global Brands Llc Novel Preparation of an Enteric Release System
US8859003B2 (en) * 2009-06-05 2014-10-14 Intercontinental Great Brands Llc Preparation of an enteric release system
US20100307542A1 (en) * 2009-06-05 2010-12-09 Kraft Foods Global Brands Llc Method of Reducing Surface Oil on Encapsulated Material
US9968564B2 (en) 2009-06-05 2018-05-15 Intercontinental Great Brands Llc Delivery of functional compounds
PT2552484T (pt) 2010-03-29 2020-04-03 Opko Ireland Global Holdings Ltd Métodos e composições para redução dos níveis de parafróides
WO2012075575A1 (en) * 2010-12-10 2012-06-14 The Governors Of The University Of Alberta Barley protein microcapsules
US8859005B2 (en) 2012-12-03 2014-10-14 Intercontinental Great Brands Llc Enteric delivery of functional ingredients suitable for hot comestible applications
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 d 방출 제형
EP3193925A2 (de) 2014-08-07 2017-07-26 OPKO Ireland Global Holdings, Ltd. Adjunktive therapie mit 25-hydroxyvitamin d
EP3197436B1 (de) * 2014-09-24 2022-03-09 Vital Beverages Global Inc. Zusammensetzungen und verfahren zur selektiven freisetzung im magendarmtrakt
CA3018328A1 (en) 2014-10-31 2016-04-30 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
BR112018069444A2 (pt) 2016-03-24 2019-10-08 Nutrinia Ltd método para promover esvaziamento gástrico num sujeito em necessidade do mesmo, insulina para uso na promoção do esvaziamento gástrico num sujeito em necessidade do mesmo e kit para uso na promoção do esvaziamento gástrico
IL290855B1 (en) 2016-03-28 2024-02-01 Eirgen Pharma Ltd Treatment methods using vitamin D
US10849938B2 (en) 2017-09-13 2020-12-01 ZBiotics Company Gene expression system for probiotic microorganisms
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2895880A (en) * 1955-05-13 1959-07-21 Smith Kline French Lab Sustained release pharmaceutical product
NL251030A (de) * 1959-04-30
US3117027A (en) * 1960-01-08 1964-01-07 Wisconsin Alumni Res Found Apparatus for coating particles in a fluidized bed
GB935672A (en) * 1960-07-19 1963-09-04 Sterling Drug Inc Sustained release tablet
US3196827A (en) * 1962-11-19 1965-07-27 Wisconsin Alumni Res Found Apparatus for the encapsulation of discrete particles
US3253944A (en) * 1964-01-13 1966-05-31 Wisconsin Alumni Res Found Particle coating process
US3241520A (en) * 1964-10-19 1966-03-22 Wisconsin Alumni Res Found Particle coating apparatus
US3558768A (en) * 1969-12-19 1971-01-26 Sterling Drug Inc Sustained release pharmaceutical compositions
US3802896A (en) * 1972-05-15 1974-04-09 Nutrilite Products Color concentrated base dispersion used in tablet film coating
US3939259A (en) * 1974-05-24 1976-02-17 Anthony Pescetti Coating composition and therapeutic preparation incorporating same
US3996355A (en) * 1975-01-02 1976-12-07 American Home Products Corporation Permanent suspension pharmaceutical dosage form
US4137300A (en) * 1976-08-20 1979-01-30 Ciba-Geigy Corporation Sustained action dosage forms
US4323312A (en) * 1977-08-26 1982-04-06 Werner Glatt Fluidized bed apparatus
US4308251A (en) * 1980-01-11 1981-12-29 Boots Pharmaceuticals, Inc. Controlled release formulations of orally-active medicaments
US4384004A (en) * 1981-06-02 1983-05-17 Warner-Lambert Company Encapsulated APM and method of preparation
US4704284A (en) * 1982-08-12 1987-11-03 Pfizer Inc. Long-acting matrix tablet formulations
US4525339A (en) * 1982-10-15 1985-06-25 Hoffmann-La Roche Inc. Enteric coated oral dosage form
JPS59220175A (ja) * 1983-05-28 1984-12-11 Furointo Sangyo Kk 健康食品のコ−テイング方法
US4876094A (en) * 1984-01-13 1989-10-24 Battelle Development Corporation Controlled release liquid dosage formulation
NZ210785A (en) * 1984-01-13 1987-11-27 Battelle Development Corp Liquid dispersions of layered controlled release dosage forms
JPS60221078A (ja) * 1984-04-18 1985-11-05 Morinaga Milk Ind Co Ltd 有用微生物粉末の粒状製品およびその製造法
JPS61141862A (ja) * 1984-12-17 1986-06-28 Furointo Sangyo Kk 可食性徐放性顆粒
BR8506634A (pt) * 1984-12-20 1986-09-09 Rhone Poulenc Sante Composicoes para o revestimento de aditivos alimentares destinados aos ruminantes e granulados sob forma de microcapsulas assim revestidos
US4892742A (en) * 1985-11-18 1990-01-09 Hoffmann-La Roche Inc. Controlled release compositions with zero order release
JPS62201823A (ja) * 1986-02-28 1987-09-05 Freunt Ind Co Ltd 腸内有用細菌含有物およびその製造方法
EP0318512B1 (de) * 1986-08-18 1998-06-17 Emisphere Technologies, Inc. Verabreichungssysteme für arzneimittel
GB8628728D0 (en) * 1986-12-02 1987-01-07 Euro Celtique Sa Spheroids
JPS63151353A (ja) * 1986-12-15 1988-06-23 Oogawara Kakoki Kk ワツクスコ−テイングマイクロカプセルの製造方法
SE8605515D0 (sv) * 1986-12-22 1986-12-22 Astra Laekemedel Ab A liquid dosage form for oral administration of a pharmaceutically active substance
US4895725A (en) * 1987-08-24 1990-01-23 Clinical Technologies Associates, Inc. Microencapsulation of fish oil
FR2624351B1 (fr) * 1987-12-15 1991-11-22 Rhone Poulenc Sante Compositions degradables par voie enzymatique utilisables pour l'enrobage d'additifs alimentaires destines aux ruminants
FI101344B1 (fi) * 1988-03-31 1998-06-15 Tanabe Seiyaku Co Menetelmä valmistaa valmiste, josta kontrolloidusti vapautuu farmaseuttisesti aktiivista ainetta
IL92344A0 (en) * 1989-01-04 1990-07-26 Gist Brocades Nv Microencapsulation of bioactive substances in biocompatible polymers,microcapsules obtained and pharmaceutical preparation comprising said microcapsules
US4983402A (en) * 1989-02-24 1991-01-08 Clinical Technologies Associates, Inc. Orally administerable ANF
US4976968A (en) * 1989-02-24 1990-12-11 Clinical Technologies Associates, Inc. Anhydrous delivery systems for pharmacological agents
DE3911903A1 (de) * 1989-04-12 1990-10-18 Bosch Gmbh Robert Verdraengerpumpe zum foerdern eines mediums
US5077053A (en) * 1990-02-12 1991-12-31 Warner-Lambert Company Zein as a moisture barrier for sugarless edible compositions and method for preparing same
IT1246382B (it) * 1990-04-17 1994-11-18 Eurand Int Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon
AU8219191A (en) * 1990-06-14 1992-01-07 Kalmo Enterprises, Inc. Stable aqueous drug suspensions

Also Published As

Publication number Publication date
MX9207263A (es) 1993-06-01
CA2122592A1 (en) 1993-07-08
EP0619733B1 (de) 2001-08-16
US5160742A (en) 1992-11-03
EP0619733A4 (de) 1995-06-07
CA2122592C (en) 1997-08-05
AU3418993A (en) 1993-07-28
DE69232007T2 (de) 2002-04-18
WO1993012772A1 (en) 1993-07-08
EP0619733A1 (de) 1994-10-19

Similar Documents

Publication Publication Date Title
DE69232007T2 (de) Abgabesystem für eine wirksubstanz mit verzögerter freisetzung
FI961437A (fi) Vaikuttavan aineen luovuttava systeemi
DK0528310T3 (da) Transportsystem
KR950703831A (ko) 신뢰성있는 메시지 전달 시스템(Reliable Message Delivery System)
DE69133445D1 (de) Arzneistoffabgabesystem
BR9105833A (pt) Sistema de contencao para agroquimicos e semelhantes
DE69017595D1 (de) Automatisches Transportsystem.
IT8321957A0 (it) Dispositivo di consegna e di svincolo per oggetti utilitari, come carrelli per bagagli.
MX9204882A (es) Sistema de fijacion para pelicula porosa
BR9003129A (pt) Sistema seringa-agulha auto-inutilizavel para injecoes
DE69314651T2 (de) Transportsystem
FI903911A0 (fi) Stoppningsanordning foer landfordon.
DE68913060D1 (de) Aufbewahrungs- und Ausgabesystem.
NO910022D0 (no) Fungiside virkestoffkombinasjoner.
IT9047959A0 (it) Sistema di trasporto bobine.
NL193363B (nl) Transportstelsel.
IT1196282B (it) Dispositivo di consegna e di svincolo di oggetti utilitari,come carrelli per bagagli
NO905404L (no) Transportanordning for anvendelse i roeykehus.
ES1023292Y (es) Banderilla perfeccionada para espectaculos taurinos.
DE69112846T2 (de) Viehfütterungsanlage.
ES1016734Y (es) Estructuracion perfeccionada para expositores frigorificos y similares.
FI894383A (fi) Transportsystem.
ES1014627Y (es) Banderin perfeccionado.
DK43191D0 (da) Transportsystem
DK109491A (da) Transportsystem

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee